Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | ILMN | ROIV | ||
| Company | Horizon Therapeutics | Illumina Inc | Roivant Sciences Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 194.35 | 35.13 | ||
| High | 116.38 | 195.04 | 35.58 | ||
| Low | 116.26 | 188.51 | 34.66 | ||
| Latest | 116.30 | 190.26 | 34.76 | ||
| Change | +0.05 | -3.83 | -0.25 | ||
| % Change | +0.04% | -1.97% | -0.71% | ||
| Volume | 28,881,200 | 879,472 | 1,311,186 | ||
| 20-Day Average Volume | 3,994,490 | 1,678,825 | 4,636,615 | ||
| Previous Close | 116.25 | 194.09 | 35.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 189.01 | 35.12 | ||
| 20-Day Raw Stochastic | 95.09% | 56.53% | 36.95% | ||
| 20-Day Relative Strength | 80.29 | 57.58 | 57.87 | ||
| Weighted Alpha | +49.30 | +100.75 | +180.66 | ||
| Today's Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +2.10% since 07/20/26 | +2.29% since 07/20/26 | ||
| Low | 115.66 on 09/29/23 | 178.88 on 07/21/26 | 34.02 on 07/21/26 | ||
| High | 116.38 on 10/05/23 | 199.14 on 07/23/26 | 35.69 on 07/23/26 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | +6.80% since 06/26/26 | +2.23% since 06/26/26 | ||
| Low | 114.75 on 09/11/23 | 174.78 on 06/30/26 | 33.56 on 07/17/26 | ||
| High | 116.38 on 10/05/23 | 199.14 on 07/23/26 | 37.00 on 07/10/26 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | +46.71% since 04/27/26 | +25.06% since 04/27/26 | ||
| Low | 98.80 on 08/03/23 | 119.14 on 04/29/26 | 27.45 on 04/29/26 | ||
| High | 116.38 on 10/05/23 | 199.14 on 07/23/26 | 37.00 on 07/10/26 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | +23.97% since 01/27/26 | +54.59% since 01/27/26 | ||
| Low | 90.56 on 05/16/23 | 112.65 on 02/12/26 | 20.98 on 02/02/26 | ||
| High | 116.38 on 10/05/23 | 199.14 on 07/23/26 | 37.00 on 07/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 29,365,818 | 25,181,642 | ||
| Shares Outstanding, K | 228,995 | 151,300 | 719,270 | ||
| Annual Sales | 3,629,040,000 | 4,343,000,000 | 8,260,000 | ||
| Annual Net Income | 521,480,000 | 850,000,000 | -299,770,000 | ||
| Last Quarter Sales | 944,960,000 | 1,091,000,000 | 2,520,000 | ||
| Last Quarter Net Income | 127,070,000 | 134,000,000 | 302,990,000 | ||
| 60-Month Beta | 1.03 | 1.47 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 1.15 on 04/30/26 | -0.36 on 05/20/26 | ||
| Earnings Date | 11/01/23 | 07/30/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 39.14 | 0.00 | ||